125 related articles for article (PubMed ID: 22658364)
1. Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist.
Itoh Y; Ishikawa M; Kitaguchi R; Okuhira K; Naito M; Hashimoto Y
Bioorg Med Chem Lett; 2012 Jul; 22(13):4453-7. PubMed ID: 22658364
[TBL] [Abstract][Full Text] [Related]
2. Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.
Itoh Y; Ishikawa M; Naito M; Hashimoto Y
J Am Chem Soc; 2010 Apr; 132(16):5820-6. PubMed ID: 20369832
[TBL] [Abstract][Full Text] [Related]
3. Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein.
Okuhira K; Ohoka N; Sai K; Nishimaki-Mogami T; Itoh Y; Ishikawa M; Hashimoto Y; Naito M
FEBS Lett; 2011 Apr; 585(8):1147-52. PubMed ID: 21414315
[TBL] [Abstract][Full Text] [Related]
4. Targeted Degradation of Proteins Localized in Subcellular Compartments by Hybrid Small Molecules.
Okuhira K; Shoda T; Omura R; Ohoka N; Hattori T; Shibata N; Demizu Y; Sugihara R; Ichino A; Kawahara H; Itoh Y; Ishikawa M; Hashimoto Y; Kurihara M; Itoh S; Saito H; Naito M
Mol Pharmacol; 2017 Mar; 91(3):159-166. PubMed ID: 27965304
[TBL] [Abstract][Full Text] [Related]
5. Development of target protein-selective degradation inducer for protein knockdown.
Itoh Y; Ishikawa M; Kitaguchi R; Sato S; Naito M; Hashimoto Y
Bioorg Med Chem; 2011 May; 19(10):3229-41. PubMed ID: 21515062
[TBL] [Abstract][Full Text] [Related]
6. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas.
Akyurek N; Ren Y; Rassidakis GZ; Schlette EJ; Medeiros LJ
Cancer; 2006 Oct; 107(8):1844-51. PubMed ID: 16983704
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion.
Vo HP; Crowe DL
Anticancer Res; 1998; 18(1A):217-24. PubMed ID: 9568080
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.
Goelden U; Pfoertner S; Hansen W; Toepfer T; von Knobloch R; Hofmann R; Buer J; Schrader AJ
Urol Int; 2005; 75(3):269-76. PubMed ID: 16215318
[TBL] [Abstract][Full Text] [Related]
9. CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells.
Chen NN; Li Y; Wu ML; Liu ZL; Fu YS; Kong QY; Chen XY; Li H; Liu J
Exp Dermatol; 2012 Jan; 21(1):13-8. PubMed ID: 22082219
[TBL] [Abstract][Full Text] [Related]
10. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
[TBL] [Abstract][Full Text] [Related]
11. The RING domain of cIAP1 mediates the degradation of RING-bearing inhibitor of apoptosis proteins by distinct pathways.
Cheung HH; Plenchette S; Kern CJ; Mahoney DJ; Korneluk RG
Mol Biol Cell; 2008 Jul; 19(7):2729-40. PubMed ID: 18434593
[TBL] [Abstract][Full Text] [Related]
12. Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative.
Tomoshige S; Nomura S; Ohgane K; Hashimoto Y; Ishikawa M
Bioorg Med Chem Lett; 2018 Feb; 28(4):707-710. PubMed ID: 29366651
[TBL] [Abstract][Full Text] [Related]
13. The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination.
Chang YF; Cheng CM; Chang LK; Jong YJ; Yuo CY
Biochem Biophys Res Commun; 2006 Apr; 342(4):1022-6. PubMed ID: 16510124
[TBL] [Abstract][Full Text] [Related]
14. Cellular inhibitor of apoptosis (cIAP1) is down-regulated during retinal ganglion cell (RGC) maturation.
Kisiswa L; Albon J; Morgan JE; Wride MA
Exp Eye Res; 2010 Nov; 91(5):739-47. PubMed ID: 20831867
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional analysis of the cellular retinoic acid binding protein from silkworm pupae (Bombyx mori).
Wang XJ; Chen J; Lv ZB; Nie ZM; Wang D; Shen HD; Wang XD; Wu XF; Zhang YZ
J Cell Biochem; 2007 Nov; 102(4):970-9. PubMed ID: 17486602
[TBL] [Abstract][Full Text] [Related]
16. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
[TBL] [Abstract][Full Text] [Related]
17. Competitive PCR demonstrates that 9-cis retinoic acid induces cellular retinoic acid-binding protein-II more efficiently than all-trans retinoic acid in human osteosarcoma cells.
Melhus H; Gobl A; Ljunghall S
Biochem Biophys Res Commun; 1994 Apr; 200(2):1125-9. PubMed ID: 8179592
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of the stem cell response to retinoic acid and synthetic retinoid analogues: identification of major retinoid-inducible proteins.
Maltman DJ; Christie VB; Collings JC; Barnard JH; Fenyk S; Marder TB; Whiting A; Przyborski SA
Mol Biosyst; 2009 May; 5(5):458-71. PubMed ID: 19381361
[TBL] [Abstract][Full Text] [Related]
19. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
[TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
